Viewing Study NCT01670032


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2025-12-25 @ 7:18 PM
Study NCT ID: NCT01670032
Status: COMPLETED
Last Update Posted: 2014-08-12
First Post: 2012-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Sponsor: NovaBay Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module